Antidiabetic and protective effects of Scrophularia striata ethanolic extract on diabetic nephropathy via suppression of RAGE and S100A8 expression in kidney tissues of streptozotocin-induced diabetic rats

References

[1] Rajashree R, Patil R, Khlokute SD, Goudar SS. Effect of Salacia reticulata W. and Clitoria ternatea L. on the cognitive and behavioral changes in the streptozotocin-induced young diabetic rats. J Basic Clin Physiol Pharmacol 2017;28:107–1410.1515/jbcpp-2016-0024Search in Google Scholar PubMed

[2] Poon TY, Ong KL, Cheung BM. Review of the effects of the traditional Chinese medicine Rehmannia Six Formula on diabetes mellitus and its complications. J diabetes 2011;3:184–200.10.1111/j.1753-0407.2011.00130.xSearch in Google Scholar PubMed

[3] Gan MJ, Albanese-O’Neill A, Haller MJ. Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research. Curr Probl Pediatr Adolesc Health Care 2012;42:269–91.10.1016/j.cppeds.2012.07.002Search in Google Scholar PubMed

[4] Kitada M, Zhang Z, Mima A, King GL. Molecular mechanisms of diabetic vascular complications. J Diabetes Investig 2010;1:77–89.10.1111/j.2040-1124.2010.00018.xSearch in Google Scholar PubMed PubMed Central

[5] Navale AM, Paranjape A. Antidiabetic and renoprotective effect of Anogeissus acuminata leaf extract on experimentally induced diabetic nephropathy. J Basic Clin Physiol Pharmacol 2018;29:359–64.10.1515/jbcpp-2017-0190Search in Google Scholar PubMed

[6] Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes 2014;5:393–8.10.4239/wjd.v5.i3.393Search in Google Scholar PubMed PubMed Central

[7] Busch M, Franke S, Rüster C, Wolf G. Advanced glycation end-products and the kidney. Eur J Clin Invest 2010;40:742–55.10.1111/j.1365-2362.2010.02317.xSearch in Google Scholar PubMed

[8] Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 2000;11:1656–66.10.1681/ASN.V1191656Search in Google Scholar PubMed

[9] Pillai SS, Sugathan JK, Indira M. Selenium downregulates RAGE and NFκB expression in diabetic rats. Biol Trace Elem Res 2012;149:71–7.10.1007/s12011-012-9401-1Search in Google Scholar PubMed

[10] Li J, Liu D, Sun L, Lu Y, Zhang Z. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci 2012;317:1–5.10.1016/j.jns.2012.02.018Search in Google Scholar PubMed

[11] Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 2009;1793[6]:993–1007.10.1016/j.bbamcr.2008.11.016Search in Google Scholar

[12] Volz HC, Laohachewin D, Seidel C, Lasitschka F, Keilbach K, Wienbrandt AR, et al. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling. Basic Res Cardiol 2012;107:250–66.10.1007/s00395-012-0250-zSearch in Google Scholar

[13] Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, et al. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 2012;55:2256–66.10.1007/s00125-012-2578-1Search in Google Scholar

[14] Li X, Xiao Y, Gao H, Li B, Xu L, Cheng M, et al. Grape seed proanthocyanidins ameliorate diabetic nephropathy via modulation of levels of AGE, RAGE and CTGF. Nephron Exp Nephrol 2009;111:31–41.10.1159/000191103Search in Google Scholar

[15] Sonia TA, Sharma CP. An overview of natural polymers for oral insulin delivery. Drug Discov Today 2012;17:784–92.10.1016/j.drudis.2012.03.019Search in Google Scholar

[16] Choi H-J, Jang H-J, Chung T-W, Jeong S-I, Cha J, Choi J-Y, et al. Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells. Fitoterapia 2013;86:19–28.10.1016/j.fitote.2013.01.014Search in Google Scholar

[17] Nasiri A, Ziamajidi N, Abbasalipourkabir R, Goodarzi MT, Saidijam M, Behrouj H, et al. Beneficial effect of aqueous garlic extract on inflammation and oxidative stress status in the kidneys of type 1 diabetic rats. Indian J Clin Biochem 2017;32:329–36.10.1007/s12291-016-0621-6Search in Google Scholar

[18] Arumugam G, Manjula P, Paari N. A review: anti diabetic medicinal plants used for diabetes mellitus. J Acute Disease 2013;2:196–200.10.1016/S2221-6189(13)60126-2Search in Google Scholar

[19] Varzaneh MB, Klevenhusen F, Zebeli Q, Petri R. Scrophularia striata extract supports rumen fermentation and improves microbial diversity in vitro compared to monensin. Front Microbiol 2018;9:1–13.10.3389/fmicb.2018.02164Search in Google Scholar

[20] Yousefbeyk F, Vatandoost H, Golfakhrabadi F, Mirzaee Z, Abai MR, Amin G, et al. Antioxidant and larvicidal activity of areal parts of Scrophularia striata against malaria vector Anopheles stephensi. J Arthropod Borne Dis 2018;12:119–26.10.18502/jad.v12i2.37Search in Google Scholar

[21] Roodsari MR, Zamanian-Azodi M, Salimpour F. Herbal remedies and medicine; introducing some Iranian plants. J Paramed Sci 2013;4:116–22.Search in Google Scholar

[22] Zahiri M, Mohebali M, Khanavi M, Sahebgharani M, Saghafipour A, Esmaeili J, et al. Therapeutic effect of scrophularia striata ethanolic extract against localized cutaneous leishmaniasis caused by Leishmania major [MRHO/IR/75/ER]. Iran J Public Health 2016;45:1340–7.Search in Google Scholar

[23] Monsef-Esfahani HR, Hajiaghaee R, Shahverdi AR, Khorramizadeh MR, Amini M. Flavonoids, cinnamic acid and phenyl propanoid from aerial parts of Scrophularia striata. Pharm Biol 2010;48:333–6.10.3109/13880200903133829Search in Google Scholar PubMed

[24] Rostami F, Ghasemi HA, Taherpour K. Effect of Scrophularia striata and Ferulago angulata, as alternatives to virginiamycin, on growth performance, intestinal microbial population, immune response, and blood constituents of broiler chickens. Poult Sci 2015;94:2202–9.10.3382/ps/pev198Search in Google Scholar PubMed

[25] Zengin G, Stefanucci A, Rodrigues MJ, Mollica A, Custodio L, Aumeeruddy MZ, et al. Scrophularia lucida L. as a valuable source of bioactive compounds for pharmaceutical applications: in vitro antioxidant, anti-inflammatory, enzyme inhibitory properties, in silico studies, and HPLC profiles. J Pharm Biomed Anal 2019;162:225–33.10.1016/j.jpba.2018.09.035Search in Google Scholar PubMed

[26] Shahbazi Y. Antibacterial and antioxidant properties of Scrophularia Striata Boiss. methanolic extract. J Pure Appl Microbiol 2017;11:1435–41.10.22207/JPAM.11.3.26Search in Google Scholar

[27] Mehrabadi ME, Salemi Z, Babaie S, Panahi M. Effect of biochanin A on retina levels of vascular endothelial growth factor, tumor necrosis factor-alpha and interleukin-1beta in rats with streptozotocin-induced diabetes. Can J Diabetes 2018;42:639–44.10.1016/j.jcjd.2018.03.008Search in Google Scholar PubMed

[28] Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.10.1093/clinchem/18.6.499Search in Google Scholar

[29] Tahara A, Kurosaki E, Yokono M, Yamajuku D, Kihara R, Hayashizaki Y, et al. Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats. J Pharm Pharmacol 2014;66:975–87.10.1111/jphp.12223Search in Google Scholar PubMed

[30] Ghasemi H, Einollahi B, Hosseini-Zijoud S-R, Farhadiannezhad M. Protective effects of curcumin on diabetic nephropathy via attenuation of kidney injury molecule 1 [KIM-1] and neutrophil gelatinase-associated lipocalin [NGAL] expression and alleviation of oxidative stress in rats with type 1 diabetes. IJBMS 2019;22:376–83.Search in Google Scholar

[31] Azadmehr A, Oghyanous KA, Hajiaghaee R, Amirghofran Z, Azadbakht M. Antioxidant and neuroprotective effects of Scrophularia striata extract against oxidative stress-induced neurotoxicity. Cell Mol Neurobiol 2013;33:1135–41.10.1007/s10571-013-9979-7Search in Google Scholar PubMed

[32] Prabhakar PK, Doble M. Interaction of cinnamic acid derivatives with commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1 adipocytes. J Agric Food Chem 2011;59:9835–44.10.1021/jf2015717Search in Google Scholar PubMed

[33] Jay MA, Ren J. Peroxisome proliferator-activated receptor [PPAR] in metabolic syndrome and type 2 diabetes mellitus. Curr Diabetes Rev 2007;3:33–9.10.2174/157339907779802067Search in Google Scholar PubMed

[34] Kasetti RB, Nabi SA, Swapna S, Apparao C. Cinnamic acid as one of the antidiabetic active principle [s] from the seeds of Syzygium alternifolium. Food Chem Toxicol 2012;50:1425–31.10.1016/j.fct.2012.02.003Search in Google Scholar PubMed

[35] Adisakwattana S, Sompong W, Meeprom A, Ngamukote S, Yibchok-anun S. Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation. Int J Mol Sci 2012;13:1778–89.10.3390/ijms13021778Search in Google Scholar

[36] Ozkol H, Tuluce Y, Dilsiz N, Koyuncu I. Therapeutic potential of some plant extracts used in Turkish traditional medicine on streptozocin-induced type 1 diabetes mellitus in rats. J Membr Biol 2013;246:47–55.10.1007/s00232-012-9503-xSearch in Google Scholar

[37] Iskender H, Dokumacioglu E, Sen TM, Ince I, Kanbay Y, Saral S. The effect of hesperidin and quercetin on oxidative stress, NF-κB and SIRT1 levels in a STZ-induced experimental diabetes model. Biomed Pharmacother 2017;90:500–8.10.1016/j.biopha.2017.03.102Search in Google Scholar

[38] Anjaneyulu M, Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2004;31:244–8.10.1111/j.1440-1681.2004.03982.xSearch in Google Scholar

[39] Sriraksa N, Wattanathorn J, Muchimapura S, Tiamkao S, Brown K, Chaisiwamongkol K. Cognitive-enhancing effect of quercetin in a rat model of Parkinson’s disease induced by 6-hydroxydopamine. Evid Based Complement Alternat Med 2012;2012:1–9.10.1155/2012/823206Search in Google Scholar

[40] Liu Y-H, Lu Y-L, Han C-H, Hou W-C. Inhibitory activities of acteoside, isoacteoside, and its structural constituents against protein glycation in vitro. Bot Stud 2013;54:1–9.10.1186/1999-3110-54-6Search in Google Scholar

[41] Nasri H, Rafieian-Kopaei M. Diabetes mellitus and renal failure: prevention and management. J Res Med Sci 2015;20:1112–2010.4103/1735-1995.172845Search in Google Scholar

[42] Sochocka M, Diniz BS, Leszek J. Inflammatory response in the CNS: friend or foe? Mol Neurobiol 2017;54:8071–89.10.1007/s12035-016-0297-1Search in Google Scholar

[43] Penfold SA, Coughlan MT, Patel SK, Srivastava PM, Sourris KC, Steer D, et al. Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int 2010;78:287–95.10.1038/ki.2010.134Search in Google Scholar

[44] Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, Cooper ME, et al. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol 2004;164:1389–97.10.1016/S0002-9440(10)63225-7Search in Google Scholar

[45] Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 2003;162:1123–37.10.1016/S0002-9440(10)63909-0Search in Google Scholar

[46] Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 2001;108:261–8.10.1172/JCI11771Search in Google Scholar PubMed PubMed Central

[47] Deng X, Sun L, Lai X, Xiang L, Li Q, Zhang W, et al. Tea polypeptide ameliorates diabetic nephropathy through RAGE and NF-κB signaling pathway in type 2 diabetes mice. J Agric Food Chem 2018;66:11957–67.10.1021/acs.jafc.8b04819Search in Google Scholar PubMed

[48] Nakajima Y, Inagaki Y, Kido J, Nagata T. Advanced glycation end products increase expression of S100A8 and A9 via RAGE–MAPK in rat dental pulp cells. Oral Dis 2015;21:328–34.10.1111/odi.12280Search in Google Scholar PubMed

[49] Lim RR, Vaidya T, Gadde SG, Yadav NK, Sethu S, Hainsworth DP, et al. Correlation between systemic S100A8 and S100A9 levels and severity of diabetic retinopathy in patients with type 2 diabetes mellitus. Diabetes Metab Syndr 2019;13:1581–910.1016/j.dsx.2019.03.014Search in Google Scholar PubMed

[50] Nagareddy PR, Murphy AJ, Stirzaker RA, Hu Y, Yu S, Miller RG, et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab 2013;17:695–708.10.1016/j.cmet.2013.04.001Search in Google Scholar PubMed PubMed Central

[51] De Ramon L, Ripoll E, Merino A, Lúcia M, Aran JM, Pérez-Rentero S, et al. CD154-CD40 T-cell co-stimulation pathway is a key mechanism in kidney ischemia-reperfusion injury. Kidney Int 2015;88:538–49.10.1038/ki.2015.146Search in Google Scholar PubMed PubMed Central